首页> 外文期刊>Die Pharmazie >Studies on gynaecological hydrophilic lactic acid preparations, Part 7: use of chitosan as lactic acid carrier in intravaginal tablets (globuli vaginales).
【24h】

Studies on gynaecological hydrophilic lactic acid preparations, Part 7: use of chitosan as lactic acid carrier in intravaginal tablets (globuli vaginales).

机译:妇科亲水性乳酸制剂的研究,第7部分:壳聚糖在阴道内片剂(小球阴道)中作为乳酸载体的用途。

获取原文
获取原文并翻译 | 示例
           

摘要

Intravaginal tablets based on hydrophilic methylcellulose and containing lactic acid complexed with chitosan undergo deformation under standard conditions.The high flow--limit of the gel originating from the tablets as well as its dynamic viscosity should ensure the durability of this dosage form on the vaginal mucosa. By selecting either ratios of lactic acid to chitosan of 1:1 or 2:1 it is possible to obtain tablets that disintegrate into a gel form at pH 3.8-4.4, i.e. the pH remains within the physiological range. Increasing the amount of lactic acid in the complex in relation to polymer to a 4:1 ratio results in gels with a lower pH while giving an acid reserve that can neutralize the excess of alkali present in severe vaginal infections.
机译:基于亲水性甲基纤维素并含有乳酸与壳聚糖复合的阴道内片剂在标准条件下会发生变形。源自片剂的凝胶的高流量限制和动态粘度应确保该剂型在阴道粘膜上的持久性。通过选择乳酸与壳聚糖的比例为1:1或2:1,可以获得在pH 3.8-4.4下崩解成凝胶形式的片剂,即pH保持在生理范围内。相对于聚合物,复合物中乳酸的含量增加到4:1的比例会导致凝胶的pH值降低,同时提供的酸储备可以中和严重阴道感染中过量的碱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号